Passage Bio, Inc. (PASG)
3.46
-0.05
(-1.42%)
USD |
NASDAQ |
Nov 05, 16:00
Passage Bio Market Cap : 11.13M for Nov. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 11.13M |
| November 04, 2026 | 11.29M |
| November 03, 2026 | 10.94M |
| November 02, 2026 | 10.68M |
| October 30, 2026 | 11.10M |
| October 29, 2026 | 11.33M |
| October 28, 2026 | 10.72M |
| October 27, 2026 | 10.78M |
| October 26, 2026 | 10.81M |
| October 23, 2026 | 10.84M |
| October 22, 2026 | 11.29M |
| October 21, 2026 | 11.55M |
| October 20, 2026 | 11.58M |
| October 19, 2026 | 11.52M |
| October 16, 2026 | 11.26M |
| October 15, 2026 | 11.58M |
| October 14, 2026 | 11.78M |
| October 13, 2026 | 11.71M |
| October 12, 2026 | 14.64M |
| October 09, 2026 | 11.87M |
| October 08, 2026 | 12.16M |
| October 07, 2026 | 12.40M |
| October 06, 2026 | 13.13M |
| October 05, 2026 | 13.16M |
| October 02, 2026 | 13.26M |
| Date | Value |
|---|---|
| October 01, 2026 | 13.52M |
| September 30, 2026 | 14.48M |
| September 29, 2026 | 14.90M |
| September 28, 2026 | 15.04M |
| September 25, 2026 | 15.45M |
| September 24, 2026 | 15.45M |
| September 23, 2026 | 16.09M |
| September 22, 2026 | 15.93M |
| September 21, 2026 | 15.54M |
| September 18, 2026 | 15.28M |
| September 17, 2026 | 16.22M |
| September 16, 2026 | 15.64M |
| September 15, 2026 | 15.35M |
| September 14, 2026 | 15.64M |
| September 11, 2026 | 16.09M |
| September 10, 2026 | 16.04M |
| September 09, 2026 | 15.90M |
| September 08, 2026 | 15.61M |
| September 04, 2026 | 14.96M |
| September 03, 2026 | 15.28M |
| September 02, 2026 | 14.83M |
| September 01, 2026 | 14.29M |
| August 31, 2026 | 14.25M |
| August 28, 2026 | 14.54M |
| August 27, 2026 | 13.93M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.599B |
| Alnylam Pharmaceuticals, Inc. | 21.22B |
| Anika Therapeutics, Inc. | 223.63M |
| Savara, Inc. | 949.97M |
| Vericel Corp. | 2.613B |
Market Cap Related Metrics
| PEG Ratio | -0.0063 |
| Price to Book Value | 2.499 |
| Price | 3.46 |
| Earnings Yield | -326.9% |
| PEGY Ratio | -0.0063 |